[go: up one dir, main page]

RS58997B1 - Composition against aging of the intimate area skin - Google Patents

Composition against aging of the intimate area skin

Info

Publication number
RS58997B1
RS58997B1 RS20181082A RSP20181082A RS58997B1 RS 58997 B1 RS58997 B1 RS 58997B1 RS 20181082 A RS20181082 A RS 20181082A RS P20181082 A RSP20181082 A RS P20181082A RS 58997 B1 RS58997 B1 RS 58997B1
Authority
RS
Serbia
Prior art keywords
skin
intimate
composition according
composition
region
Prior art date
Application number
RS20181082A
Other languages
Serbian (sr)
Inventor
Amira Dr Fazlagić
Original Assignee
Fazlagic Amira Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fazlagic Amira Dr filed Critical Fazlagic Amira Dr
Priority to RS20181082A priority Critical patent/RS58997B1/en
Priority to EP18793495.5A priority patent/EP3849672A1/en
Priority to PCT/RS2018/000015 priority patent/WO2020055278A1/en
Publication of RS20181082A1 publication Critical patent/RS20181082A1/en
Publication of RS58997B1 publication Critical patent/RS58997B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Predmetni pronalazak se odnosi na kozmetičko sredstvo, kompoziciju protiv starenja kože intimne regije, kao i na upotrebu te kompozicije. Aktivni sastojci kompozicije su inkapsulirani u lipozome.The present invention relates to a cosmetic agent, an anti-aging composition of the skin of the intimate region, as well as to the use of that composition. The active ingredients of the composition are encapsulated in liposomes.

Description

Opis pronalaska Description of the invention

Predmetni pronalazak se odnosi na kozmetičko sredstvo, kompoziciju protiv starenja kože The present invention relates to a cosmetic product, an antiaging skin composition

intimne regije, kao i na upotrebu te kompozicije. intimate regions, as well as the use of that composition.

Tehnički problem Technical problem

Tehnički problem koji se rešava ovim pronalaskom je dobijanje kompozicije namenjene nezi The technical problem solved by this invention is obtaining a composition intended for care

kože intimnog područja i sprečavanju starenja, tj gubitka elastičnosti. Predmetni pronalazak the skin of the intimate area and preventing aging, i.e. loss of elasticity. Subject invention

obezbeđuje pH vrednost intimne regije od 3,8-4,5, obezbeđuje smanjenje mogućnosti infekcije, ensures a pH value of the intimate region of 3.8-4.5, ensures a reduction in the possibility of infection,

povećanje osećaja hidriranosti kože, olakšanje intimnih odnosa, depigmentaciju. increasing the feeling of hydration of the skin, facilitating intimate relations, depigmentation.

4 4

Stanje tehnike State of the art

Evropski patent broj EP2648739 odnosi se na višenamenski gel za suvoću vagine sa direktnim i European patent number EP2648739 relates to a multipurpose vaginal dryness gel with direct and

odloženim dejstvom. Navedeni gel sadrži frakciju kolostruma obogaćenu imunoglobulinima, delayed effect. The said gel contains a colostrum fraction enriched with immunoglobulins,

faktorima rasta, hemotaksičnim faktorima i antimikrobnim/antivirusnim faktorima. Ovaj gel se growth factors, chemotactic factors and antimicrobial/antiviral factors. This gel

koristi u tretmanu za suvoću vagine i ne navodi se efekat protiv starenja. used in the treatment of vaginal dryness and no anti-aging effect is reported.

Međunarodna patentna prijava sa brojem objave WO 2017/069793 odnosi se na kompozicije International patent application publication number WO 2017/069793 relates to compositions

vaginalnog gela i postupke za njegovu upotrebu. Gel naveden u ovoj međunarodnoj prijavi vaginal gel and procedures for its use. The gel specified in this international application

rešava problem suvoće vagine. Efekat protiv starenja nije pripisan gelu, već je naveden samo solves the problem of vaginal dryness. The anti-aging effect is not attributed to the gel, it is only stated

kao jedan od efekata vitamina E. Ova prijava problem suvoće vagine rešava viskoznom as one of the effects of vitamin E. This application solves the problem of vaginal dryness with viscous

farmaceutskom kompozicijom koja sadrži gel rastvorljiv u vodi koji sadrži niacin i/ili L- arginin. a pharmaceutical composition containing a water-soluble gel containing niacin and/or L-arginine.

L-arginin se navodi kao sastojak ili kao alternativni sastojak gela. L-arginine is listed as an ingredient or as an alternative ingredient in the gel.

U stanju tehnike postoje vaginalni preparati koji se koriste za tretman suvoće vagine, ali In the state of the art, there are vaginal preparations that are used for the treatment of vaginal dryness, but

nijedan od njih se ne bavi problemom starenja intimnog područja. Preparati iz stanja tehnike none of them deal with the problem of aging of the intimate area. Preparations from the state of the art

se primenjuju vaginalno, dok se kompozicija prema predmetnoj prijavi nanosi na kožu are applied vaginally, while the composition according to the subject application is applied to the skin

intimnog područja spolja. Za žene je prihvatljiviji spoljašnji tretman putem nanošenja intimate area outside. For women, external treatment through application is more acceptable

kompozicije na intimnu regiju, nego vaginalna primena. Predmetna kompozicija sprečava promene na koži i tako doprinosi poboljšanoj cirkulaciji, smanjenoj pigmentaciji, hidrataciji kože, a preko cirkulacije daje efekte i u vagini. Kompozicija prema predmetnoj prijavi sprečava istanjenje kože stabilizacijom DNK lanca ćelija kože i podsticanjem mikrocirkulacije sa antimikrobnim dejstvom i u uslovima tačno definisane pH vrednosti (pH 3,8-4,5). Takođe nijedan od preparata poznatih iz stanja tehnike ne sadrži ovu specifičnu kombinaciju sastojaka. Ovom kompozicijom obezbeđuje se pH vrednost intimne regije od 3,8-4,5, samim tim smanjuje se mogućnost infekcije, pored toga, povećava se osećaj hidriranosti kože, olakšani su intimni odnosi, postiže se depigmentacija. Kod žena se u delu intimne regije vremenom sa starenjem povećava pH čak i do pH 6. Predmetna kompozicija utiče na promenu pH kože intimne regije tako što pH vraća na vrednost koja je optimalna – 3,8-4,5, poželjno 4,0-4,4. compositions on the intimate region, rather than vaginal application. The composition in question prevents changes in the skin and thus contributes to improved circulation, reduced pigmentation, hydration of the skin, and via circulation also has effects in the vagina. The composition according to the subject application prevents thinning of the skin by stabilizing the DNA chain of skin cells and stimulating microcirculation with an antimicrobial effect and in conditions of a precisely defined pH value (pH 3.8-4.5). Also, none of the preparations known from the prior art contain this specific combination of ingredients. This composition ensures a pH value of the intimate region of 3.8-4.5, thereby reducing the possibility of infection, in addition, the feeling of hydration of the skin increases, intimate relations are facilitated, and depigmentation is achieved. In the part of the intimate region of women, the pH increases over time with aging, even up to pH 6. The composition in question affects the change in the pH of the skin of the intimate region by returning the pH to an optimal value - 3.8-4.5, preferably 4.0-4.4.

Kompozicija se može koristiti za tuširanje (čisti kožu, hidrira kožu...), umesto lubrikanta, smanjuje ožiljna tkiva i ima hipoalergijsko dejstvo. The composition can be used for showering (cleanses the skin, hydrates the skin...), instead of a lubricant, reduces scar tissue and has a hypoallergenic effect.

Različite klinike širom sveta se bave tretmanom protiv starenja intimne zone, ali one to postižu hirurškim procedurama ili injektiranjem npr. hijaluronske kiseline. Various clinics around the world deal with anti-aging treatment of the intimate area, but they achieve this through surgical procedures or injections, for example. hyaluronic acid.

U stanju tehnike ne postoji tretman protiv starenja intimne zone koji bi bio neinvanzivan. Takođe, što je invazivnost tretmana manja to je on prihvatljivi kod žena. Na tržištu ne postoje definisani preparati za negu kože intimnog predela, a pogotovu ne postoje sa ovim aktivnim supstancama u lipozomskom obliku u jednom preparatu sa koncentracijom arginina do oko 20%. In the state of the art, there is no anti-aging treatment for the intimate area that would be non-invasive. Also, the less invasive the treatment is, the more acceptable it is for women. There are no defined preparations for the care of the skin of the intimate area on the market, and especially none with these active substances in liposomal form in one preparation with an arginine concentration of up to about 20%.

Još jedna prednost predmetnog pronalaska je to što nema efekta ,,curenja“ kompozicije, jer kompozicija nije u obliku vodenog rastvora, već je unutar lipozoma. Another advantage of the present invention is that there is no effect of "leakage" of the composition, because the composition is not in the form of an aqueous solution, but inside a liposome.

Izlaganje suštine pronalaska Presentation of the essence of the invention

Termin „intimna regija/zona“ označava spoljašnje polne organe žene i međicu, odnosno velike i male usmine, klitoris, otvor vagine i međicu. The term "intimate region/zone" means a woman's external genitalia and perineum, i.e. labia majora and minora, clitoris, vaginal opening and perineum.

Koža intimnog dela koja obuhvata spoljne polne organe žene ima niz specifičnosti i posebnih problema koji su izraženi samo u ovoj regiji. Ovaj deo kože ima svoj specifičan pH od 3,8-4,5 koji је niži od ostalih delova kože, upravo da bi predstavljao odbranu od različitih infekcija. Takođe, u ovom delu epitel prelazi od pločasto-slojevitog sa orožavanjem u pločastoslojevit, i sama ta granica promene epitela predstavlja tačku rizika za delovanje štetnih agenasa, toksina i mikroba. Ovaj predeo kože je jako izložen mehaničkim lezijama i oštećenju površinskih delova kože. Svaki odlazak do toaleta, svaki seksualni odnos, stvara male mikrolezije koje narušavaju i pH i strukturu kože koja gubi svoje dobre osobine, a to su elastičnost, hidriranost i kompaktnost. Sam porođaj podrazumeva stvaranje ozbiljnih i neprijatnih ožiljaka u ovoj regiji za koje do sada nije postojao kontinuirani tretman nakon završetka faze zarastanja. Promena osobina kože ovog predela, tj. njeno starenje, promena pH i smanjenje debljine i elastičnosti dovode do direktnog negativnog uticaja na reproduktivno i opšte zdravlje žena. Ovom negom postiže se da pH bude optimalan i da služi kao prva odbrana od infekcija, a aktivni sastojci koji su inkorporisani u fosfolipidne lipozome dovode do povećane prokrvljenosti tkiva, velike eliminacije slobodnih radikala u ćelijama, stabilizacije DNK lanca ćelija i velike hidriranosti. Ova poboljšanja u metabolizmu kože ove regije dovode do toga da prestaje osećaj suvoće, smanjuju se infekcije, a seksualni odnosi su olakšani i prijatniji. The skin of the intimate part, which includes the external genital organs of a woman, has a number of specificities and special problems that are expressed only in this region. This part of the skin has its own specific pH of 3.8-4.5, which is lower than other parts of the skin, precisely to represent a defense against various infections. Also, in this part, the epithelium changes from squamous-layered with armature to squamous-layered, and the very border of the change of the epithelium represents a point of risk for the action of harmful agents, toxins and microbes. This area of the skin is highly exposed to mechanical lesions and damage to the surface parts of the skin. Every trip to the toilet, every sexual intercourse, creates small microlesions that disrupt the pH and structure of the skin, which loses its good properties, namely elasticity, hydration and compactness. Childbirth itself involves the creation of serious and unpleasant scars in this region, for which until now there has been no continuous treatment after the end of the healing phase. Change in the properties of the skin of this area, i.e. its aging, pH change and decrease in thickness and elasticity lead to a direct negative impact on reproductive and general health of women. With this care, it is achieved that the pH is optimal and serves as the first defense against infections, and the active ingredients that are incorporated into phospholipid liposomes lead to increased tissue blood flow, a large elimination of free radicals in the cells, stabilization of the DNA chain of cells and high hydration. These improvements in the metabolism of the skin of this region lead to the cessation of dryness, reduced infections, and easier and more pleasant sexual intercourse.

Nepovoljni faktori kao što su mikrolezije, teško održavanje pH intimne regije, izloženost infekcijama, ožiljci, svi imaju uticaja na kožu intimne regije i dovode do njenog bržeg starenja. Unfavorable factors such as microlesions, difficult maintenance of the pH of the intimate region, exposure to infections, scars, all have an impact on the skin of the intimate region and lead to its faster aging.

Ovom kompozicijom obezbeđuje se pH vrednost intimne regije od 3,8-4,5, samim tim smanjuje se mogućnost infekcije, pored toga, povećava se osećaj hidriranosti kože, olakšani su intimni odnosi, postiže se depigmentacija. Kod žena se u delu intimne regije vremenom sa starenjem povećava pH čak i do pH 6. Predmetna kompozicija utiče na promenu pH kože intimne regije tako što pH vraća na vrednost koja je optimalna - 3,8-4,5, poželjno 4,0-4,4. This composition ensures a pH value of the intimate region of 3.8-4.5, thereby reducing the possibility of infection, in addition, the feeling of hydration of the skin increases, intimate relations are facilitated, and depigmentation is achieved. In the part of the intimate region in women, the pH increases over time with aging, even up to pH 6. The subject composition affects the change in the pH of the skin of the intimate region by returning the pH to an optimal value - 3.8-4.5, preferably 4.0-4.4.

Problem predmetnog pronalaska rešava se kompozicijom koja sadrži: L-arginin, kurkumu, hijaluronsku kiselinu ili njenu so, mlečnu kiselinu i vitamin E kao aktivne sastojke inkapsulirane u lipozome. The problem of the present invention is solved by a composition containing: L-arginine, turmeric, hyaluronic acid or its salt, lactic acid and vitamin E as active ingredients encapsulated in liposomes.

Predmetna kompozicija može dodatno da sadrži lecitin, glicerol i/ili jedan ili više konzervanasa, npr., kalijum-sorbat i/ili natrijum benzoat. The subject composition may additionally contain lecithin, glycerol and/or one or more preservatives, eg, potassium sorbate and/or sodium benzoate.

Predmetna kompozicija može dodatno da sadrži vitamin C, niacin i/ili lizin. The subject composition may additionally contain vitamin C, niacin and/or lysine.

U našem proizvodu su zastupljeni L-arginin, derivat bele kurkume, hijalorunska kiselina ili njena so, mlečna kiselina i tokoferol (vitamin E). Our product contains L-arginine, a derivative of white turmeric, hyaluronic acid or its salt, lactic acid and tocopherol (vitamin E).

Predmetna kompozicija sadrži oko 20% arginina, što je omogućeno preko upotrebe lipozoma unutar kojih su sadržane aktivne supstance predmetne kompozicije. Upotreba lipozoma omogućava da aktivni sastojci dopiru do corneum-a kože, a ne u cirkulaciju. The composition in question contains about 20% of arginine, which is made possible through the use of liposomes that contain the active substances of the composition in question. The use of liposomes allows the active ingredients to reach the corneum of the skin and not into the circulation.

U poželjnom primeru izvođenja kompozicija je u obliku gela. In a preferred embodiment, the composition is in the form of a gel.

Dejstvo L-arginina u koži je potvrđeno mnogim naučnim radovima i utvrđeno je da podstiče cirkulaciju u koži, podstiče rad hormona rasta, stimuliše fibroblaste i sprečava stanjivanje kože. Takodje sprečava dejstvo slobodnih radikala pre nego što dovedu do oštećenja DNK lanca i na taj način produžava život ćelije. L-arginin takođe pomaže u zarastanju rana i koristi se u nekim kozmetičkim preparatima za negu kože lica, ali ono što čini naš preparat jedinstvenim to je koncentracija L-arginina od oko 20 % koja nije zastupljena niti u jednom poznatom preparatu za negu kože. The effect of L-arginine in the skin has been confirmed by many scientific works and it has been found to stimulate circulation in the skin, stimulate the work of growth hormones, stimulate fibroblasts and prevent thinning of the skin. It also prevents the action of free radicals before they lead to damage to the DNA chain and thus prolongs the life of the cell. L-arginine also helps in wound healing and is used in some cosmetic preparations for facial skin care, but what makes our preparation unique is the L-arginine concentration of about 20%, which is not present in any known skin care preparation.

Kurkuma dokazano utiče na sprečavanje pigmentacije kože, ima izrazito antimikrobno dejstvo i jedan je od najjačih antioksidanata. Turmeric is proven to prevent skin pigmentation, has a distinct antimicrobial effect and is one of the strongest antioxidants.

Hijaluronska kiselina je poznata i široko korišćena u kozmetici kao važan činilac hidratacije kože i stimulator kolagena. Hyaluronic acid is known and widely used in cosmetics as an important skin hydration factor and collagen stimulator.

Tokoferol je veoma čest sastojak preparata koji povećava aktivnost enzima u ćelijama kože, hidrira i ima antioksidativno dejstvo. Tocopherol is a very common ingredient in preparations that increases the activity of enzymes in skin cells, hydrates and has an antioxidant effect.

Mlečna kiselina je u ovom preparatu jako važna jer se sa njom postiže idealan pH, ali ima pozitivni uticaj i na eksfoliaciju odumrlih slojeva kože, smanjenje pigmentacije i jačanje teksture kože. Lactic acid is very important in this preparation because it achieves the ideal pH, but it also has a positive effect on the exfoliation of dead skin layers, reduction of pigmentation and strengthening of skin texture.

Sve ove sastojke pronalazači predmetnog pronalaska su inkorporisali u fosfolipodne lipozome koji se koriste kao nosači aktivnih supstanci. Fosfolipidni lipozomi imaju istu strukturu kao ćelijska membrana, pa sami po sebi prijanjaju uz nju i imaju efekat sprečavanja gubitka vode iz ćelija. Takodje njihova struktura omogućava transport aktivnih supstanci u dublje slojeve kože gde one u stvari i ostvaruju svoje biološko dejstvo i omogućavaju i velikim molekulima, kao što je hijaluronska kiselina, da budu apsorbovani i transportovani kroz ćelijsku membranu što je inače nemoguće postići drugim vrstama nosača. All these ingredients were incorporated by the inventors of the present invention into phospholipid liposomes that are used as active substance carriers. Phospholipid liposomes have the same structure as the cell membrane, so they stick to it by themselves and have the effect of preventing the loss of water from the cells. Also, their structure enables the transport of active substances into the deeper layers of the skin, where they actually achieve their biological effect and allow even large molecules, such as hyaluronic acid, to be absorbed and transported through the cell membrane, which is otherwise impossible to achieve with other types of carriers.

Kако će dalje biti opisano u delu sa primerima, predmetna kompozicija predstavlja kombinaciju sastojaka koja daje sinergistički efekat u odnosu na pojedinačne sastojke u vezi sa sledećim biofizičkim parametrima kože ispitanika: EC-kao mera vlažnosti kože, TEGV- transepidermalni gubitak vode kao mera barijernih svojstava kože, sadržaj površinskih lipida, El-eritema indeks i MI-melanin indeks. As will be further described in the section with examples, the composition in question represents a combination of ingredients that gives a synergistic effect in relation to the individual ingredients in relation to the following biophysical parameters of the skin of the subject: EC-as a measure of skin moisture, TEGV-transepidermal water loss as a measure of skin barrier properties, surface lipid content, El-erythema index and MI-melanin index.

Detaljan opis pronalaska Detailed description of the invention

Primer 1 Example 1

Pripremljena je kompozicija protiv starenja kože intimne regije u obliku intimnog lipozomskog gela sa sledećim sastavom: A composition against aging of the skin of the intimate region was prepared in the form of an intimate liposomal gel with the following composition:

Sastojci iz gore navedene tabele su ugrađeni u lipozome. Lipozomi su automatski formirani mešanjem fosfolipida iz lecitina sa rastvorom L-arginina u vodi. Sistem je formiran upotrebom mešanja visoke brzine i postupaka proizvodnje pod visokim pritiskom. (izvor: Liposomes, a practical approach, edited by Vladimir P. Torchilin et al, Oxford university press, second edition). The ingredients from the table above are incorporated into liposomes. Liposomes were automatically formed by mixing phospholipids from lecithin with a solution of L-arginine in water. The system is formed using high speed mixing and high pressure manufacturing processes. (source: Liposomes, a practical approach, edited by Vladimir P. Torchilin et al, Oxford university press, second edition).

Primer 2 Example 2

Lipozomski intimni gel opisan u Primeru 1 je primenjen na žene starosti 25 do 70 godina. U toku dve godine 80 žena je isprobalo ovaj gel i u mladjoj grupi došlo je do izrazitog poboljšanja u osećaju prokrvljenosti regije i poboljšanju senzitivnosti tokom polnih odnosa, a u starijoj grupi je došlo do značajnog povećanja hidriranosti i osećanja prokrvljenosti regije. Kod žena iz grupe od 55 do 70 godina posle redovne upotrebe preparata došlo je do popravljanja kvaliteta tkiva i omogućavanja polnih odnosa koje ranije zbog suvoće nisu mogle da ostvare. The liposomal intimate gel described in Example 1 was administered to women aged 25 to 70 years. In the course of two years, 80 women tried this gel and in the younger group there was a marked improvement in the feeling of blood supply to the region and improved sensitivity during sexual intercourse, and in the older group there was a significant increase in hydration and the feeling of blood supply to the region. In women from the age group of 55 to 70 years, after regular use of the preparation, there was an improvement in the quality of the tissues and the possibility of sexual intercourse, which they could not achieve before due to dryness.

Ispitivanje je izvršeno između oktobra 2016. i januara 2018. Izabrano je 80 ginekološki zdravih žena, seksualno aktivnih, različitog životnog doba, koje su 30 dana svakodnevno koristile preparat i nakon upotrebe su kontrolisane i popunjavale su upitnik. The examination was carried out between October 2016 and January 2018. 80 gynecologically healthy women, sexually active, of different ages were selected, who used the preparation daily for 30 days and were checked after use and filled out a questionnaire.

Ispitivan je pH kože intimne regije pre i nakon 30 dana od početka upotrebe preparata. pHje meren na samom otvoru vagine (introitusu) pomoću rukavice za kontrolu pH vrednosti CarePlan VpH proizvođača INVERNESS MEDICAL GMBH. The pH of the skin of the intimate region was examined before and after 30 days from the start of using the preparation. pH was measured at the opening of the vagina (introitus) using the CarePlan VpH pH control glove manufactured by INVERNESS MEDICAL GMBH.

Optimalan pH kože intimne regije je 4,0-4,4. The optimal pH of the skin of the intimate region is 4.0-4.4.

Broj ispitanica po starosnim grupama koje su na početku ispitivanja imale optimalan pH izražen u procentima: The number of test subjects by age group who had an optimal pH at the beginning of the test, expressed as a percentage:

Na početku ispitivanja, od svih 80 ispitanica, 30 je imalo normalan pH kože intimne regije (4,0-4,4), što predstavlja 37,5% ukupnog broja. Nakon 30 dana svakodnevne upotrebe preparata normalan pH kože intimne regije imalo je 82,5% od svih ispitanica. Ovaj rezultat pokazuje statistički značajnu promenu u postizanju normalnog pH upotrebom preparata. Najizraženiji efekat je postignut kod starijih starosnih grupa gde se zbog gubitka estrogena javlja najveći problem sa optimalnom pH vrednošću. Osećaj bolje hidriranosti kože intimne regije posle 30 dana svakodnevne upotrebe preparata u opisnoj oceni ,,malo“ i ,,znatno“ je utvrđen kod 63 ispitanice, odnosno kod 79% ispitanica, a od toga ,,znatno“ poboljšanje je imalo 33 ispitanice, odnosno 41%. Ovo pokazuje veliku statističku značajnost. Ispitivanje poboljšanja kvaliteta intimnih odnosa posle 30 dana svakodnevne upotrebe preparata pokazalo je da je kod 64 ispitanice došlo do ,,malog“ i ,,znatnog“ poboljšanja kvaliteta intimnih odnosa, što čini 80% ukupnog broja ispitanica, a od toga ,,znatno“ poboljšanje je imalo 26 ispitanica, odnosno 32,5%. I ovaj rezultat ukazuje na veliku statističku značajnost. At the beginning of the study, out of all 80 subjects, 30 had a normal pH of the skin of the intimate region (4.0-4.4), which represents 37.5% of the total number. After 30 days of daily use of the preparation, 82.5% of all test subjects had a normal pH of the skin of the intimate region. This result shows a statistically significant change in achieving a normal pH with the use of the preparation. The most pronounced effect is achieved in older age groups, where due to the loss of estrogen, the biggest problem with the optimal pH value occurs. The feeling of better hydration of the skin of the intimate region after 30 days of daily use of the preparation in the descriptive rating of "slight" and "significant" was determined in 63 subjects, i.e. 79% of the subjects, of which 33 subjects, i.e. 41%, had a "significant" improvement. This shows great statistical significance. The examination of the improvement in the quality of intimate relations after 30 days of daily use of the preparation showed that in 64 subjects there was a "small" and "significant" improvement in the quality of intimate relationships, which accounts for 80% of the total number of respondents, and of those, 26 respondents, or 32.5%, had a "significant" improvement. And this result indicates great statistical significance.

Ova studija je pokazala da upotreba ovog preparata donosi značajne pozitivne kvalitativne promene za intimno zdravlje žene i poboljšanje opšteg kvaliteta života. This study showed that the use of this preparation brings significant positive qualitative changes for a woman's intimate health and improvement of the general quality of life.

Primer 3 Example 3

Ispitivanje efikasnosti preparata na zdravoj koži ispitanika-dobrovoljaca Examination of the effectiveness of the preparation on the healthy skin of subjects-volunteers

Ispitana je efikasnost nakon primene preparata na zdravu kožu ispitanika-dobrovoljaca. Efficacy was tested after application of the preparation on the healthy skin of test subjects-volunteers.

Sprovedena je dugotrajna studija ispitivanja efikasnosti preparata na zdravu kožu (4 nedelje aplikacije). A long-term study of the effectiveness of the preparation on healthy skin was conducted (4 weeks of application).

In vivo ispitivanje efikasnosti na zdravojkoži In vivo efficacy testing on healthy skin

In vivo ispitivanje efikasnosti uzoraka vršeno je u dugotrajnoj, duplo slepoj studiji merenjem biofizičkih parametara kože ispitanika (EC-kao mera vlažnosti kože, TEGV-transepidermalni gubitak vode kao mera barijernih svojstava kože, sadržaj površinskih lipida, El-eritema indeks i MI-melanin indeks). In vivo testing of the effectiveness of the samples was performed in a long-term, double-blind study by measuring the biophysical parameters of the subjects' skin (EC-as a measure of skin moisture, TEGV-transepidermal water loss as a measure of skin barrier properties, surface lipid content, El-erythema index and MI-melanin index).

Protokol ispitivanja Test protocol

U studiji su učestvovali zdravi ispitanici. Ispitivanje je sprovedeno u toku avgusta i septembra meseca 2018. Ispitanicima je predočeno da u toku trajanja, kao ni jednu sedmicu pre početka studije, ne koriste bilo kakva sredstva za negu kože u ispitivanom predelu (koža unutrašnje strane podlaktice). Aplikovan je ispitivani preparat kao i preparat koji sadrži pojedinačne aktivne principe u koncentraciji u kojoj su prisutni u ispitivanom proizvodu. Healthy subjects participated in the study. The study was conducted in August and September 2018. The subjects were instructed not to use any skin care products in the examined area (the skin of the inner forearm) during the study period, as well as for one week before the start of the study. The tested preparation was applied as well as the preparation containing individual active principles in the concentration in which they are present in the tested product.

Nakon izvršenog inicijalnog merenja (pre početka studije, bazalne vrednosti) dobrovoljcima su date instrukcije da preparat aplikuju kod kuće jedanput dnevno, uveče, nakon tuširanja u predeo markirane površine kože u toku 4 nedelje. Merenja su vršena pre početka aplikacije (bazalne vrednosti) kao i nakon 1, 2 odnosno 4 nedelje primene. Takođe, merenja su izvršena i 4 dana po prestanku aplikacije After the initial measurement (before the start of the study, basal values) the volunteers were given instructions to apply the preparation at home once a day, in the evening, after showering in the area of the marked skin surface for 4 weeks. Measurements were performed before the start of the application (basal values) as well as after 1, 2 and 4 weeks of application. Also, measurements were taken 4 days after the application was stopped

U skladu sa dobijenim rezultatima, zaključujemo da ispitivani preparat statistički značajno povećava vlažnost kože nakon 7 dana primene (u odnosu na bazalnu vrednost) i nivo hidratacije održava se na statistički značajnom nivou sve vreme ispitivanja (4 nedelje primene). Sve vreme ispitivanja preparat ima statistički značajan uticaj na TEGV u smislu njegovog smanjenja u odnosu na bazalnu vrednost, što ukazuje na pozitivan uticaj na barijerna svojstva kože. Sadržaj površinskih lipida se povećava na koži tretiranoj ispitivanim preparatom od 7. dana aplikacije, tokom celokupnog perioda primene, što ukazuje na stvaranje tankog fosfolipidnog filma na površini kože kao posledice aplikacije lipozoma na kožu. Povećanje MI i EI ukazuje na antiiritantni uticaj ispitivanog preparata. Svi mereni parametri bili su statistički značajno bolji kod ispitivanog preparata u odnosu na preparate koji sadrže pojedinačne aktivne principe, značajno bolji i od prostog zbira efekata pojedinačnih preparata što ukazuje na sinergistički efekat odabranih aktivnih principa. In accordance with the obtained results, we conclude that the tested preparation statistically significantly increases the moisture of the skin after 7 days of application (compared to the basal value) and the level of hydration is maintained at a statistically significant level throughout the test (4 weeks of application). Throughout the test, the preparation has a statistically significant effect on TEGV in terms of its reduction compared to the basal value, which indicates a positive effect on the barrier properties of the skin. The content of surface lipids increases on the skin treated with the tested preparation from the 7th day of application, during the entire application period, which indicates the formation of a thin phospholipid film on the skin surface as a result of liposome application to the skin. The increase in MI and EI indicates the anti-irritant effect of the tested preparation. All measured parameters were statistically significantly better with the tested preparation compared to preparations containing individual active principles, significantly better than the simple sum of the effects of individual preparations, which indicates a synergistic effect of the selected active principles.

Claims (12)

Patentni zahteviPatent claims 1. Kompozicija naznačena time što sadrži L-arginin, kurkumu, hijaluronsku kiselinu ili njenu so, mlečnu kiselinu i vitamin E inkapsulirane u lipozome.1. A composition characterized by containing L-arginine, turmeric, hyaluronic acid or its salt, lactic acid and vitamin E encapsulated in liposomes. 2. Kompozicija prema patentnom zahtevu 1, naznačena time što dodatno sadrži lecitin, glicerol i/ili jedan ili više konzervanasa.2. Composition according to patent claim 1, characterized in that it additionally contains lecithin, glycerol and/or one or more preservatives. 3. Kompozicija prema patentnom zahtevu 2, naznačena time što su konzervansi kalijumsorbat i/ili natrijum benzoat.3. Composition according to claim 2, characterized in that the preservatives are potassium sorbate and/or sodium benzoate. 4. Kompozicija prema bilo kom od prethodnih patentnih zahteva, naznačena time što sadrži oko 20% L-arginina.4. A composition according to any of the preceding claims, characterized in that it contains about 20% L-arginine. 5. Kompozicija prema bilo kom od prethodnih patentnih zahteva, naznačena time što sadrži sledeće sastojke ugrađene u lipozome:5. A composition according to any of the preceding claims, characterized in that it contains the following ingredients incorporated into liposomes: 6. Kompozicija prema bilo kom od prethodnih patentnih zahteva, naznačena time što dodatno sadrži vitamin C, niacin i/ili lizin.6. A composition according to any of the preceding patent claims, characterized in that it additionally contains vitamin C, niacin and/or lysine. 7. Kompozicija prema bilo kom od prethodnih patentnih zahteva, naznačena time što je u obliku gela.7. The composition according to any of the preceding claims, characterized in that it is in the form of a gel. 8. Neterapeutska kozmetička upotreba kompozicije prema bilo kom od prethodnih patentnih zahteva za tretman protiv starenja kože intimne regije.8. Non-therapeutic cosmetic use of the composition according to any of the preceding patent claims for antiaging treatment of the skin of the intimate region. 9. Neterapeutska kozmetička upotreba kompozicije prema patentnom zahtevu 8 za postizanje pH 3,8-4,5 intimne regije.9. Non-therapeutic cosmetic use of the composition according to patent claim 8 for achieving pH 3.8-4.5 of the intimate region. 10. Neterapeutska kozmetička upotreba kompozicije prema patentnom zahtevu 9 za postizanje pH 4,0-4,4 intimne regije.10. Non-therapeutic cosmetic use of the composition according to claim 9 for achieving pH 4.0-4.4 of the intimate region. 11. Neterapeutska kozmetička upotreba kompozicije prema patentnom zahtevu 8 protiv pigmentacije kože intimne regije.11. Non-therapeutic cosmetic use of the composition according to patent claim 8 against pigmentation of the skin of the intimate region. 12. Neterapeutska kozmetička upotreba kompozicije prema patentnom zahtevu 8 kao lubrikanta za intimnu regiju.12. Non-therapeutic cosmetic use of the composition according to claim 8 as a lubricant for the intimate region.
RS20181082A 2018-09-14 2018-09-14 Composition against aging of the intimate area skin RS58997B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RS20181082A RS58997B1 (en) 2018-09-14 2018-09-14 Composition against aging of the intimate area skin
EP18793495.5A EP3849672A1 (en) 2018-09-14 2018-09-26 Composition against ageing of the intimate area skin
PCT/RS2018/000015 WO2020055278A1 (en) 2018-09-14 2018-09-26 Composition against ageing of the intimate area skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RS20181082A RS58997B1 (en) 2018-09-14 2018-09-14 Composition against aging of the intimate area skin

Publications (2)

Publication Number Publication Date
RS20181082A1 RS20181082A1 (en) 2019-02-28
RS58997B1 true RS58997B1 (en) 2019-08-30

Family

ID=64017420

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20181082A RS58997B1 (en) 2018-09-14 2018-09-14 Composition against aging of the intimate area skin

Country Status (3)

Country Link
EP (1) EP3849672A1 (en)
RS (1) RS58997B1 (en)
WO (1) WO2020055278A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1250748B (en) * 1991-08-02 1995-04-21 Poli Ind Chimica Spa USEFUL FORMULATIONS FOR THE TREATMENT OF VAGINAL DRYNESS
AU7880700A (en) * 1999-08-16 2001-03-13 Dung Phan Compositions and methods of treatment for skin conditions using extracts of turmeric
ES2747978T3 (en) * 2005-10-03 2020-03-12 Mark A Pinsky Non-phospholipid liposomes comprising hyaluronic acid
US9265792B2 (en) * 2005-11-16 2016-02-23 Patricia A. Riley Integument cell regeneration formulation
ITMI20060122A1 (en) * 2006-01-25 2007-07-26 Polichem Sa COMPOSITIONS FOR VAGINAL USE
WO2008079898A1 (en) * 2006-12-20 2008-07-03 Pharmwest, Inc. Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions
IT1405998B1 (en) 2010-12-09 2014-02-06 Bionest Ltd MULTIPURPOSE GEL AGAINST THE VAGINAL DRYNESS WITH A DIRECT AND DELAYED EFFECT
WO2013030794A2 (en) * 2011-08-31 2013-03-07 Behrooz Kasraee Use of substituted pyridines as skin depigmenting compounds
WO2017069793A1 (en) 2015-10-22 2017-04-27 Enertopia Corporation Vaginal gel compositions and methods of use thereof

Also Published As

Publication number Publication date
RS20181082A1 (en) 2019-02-28
EP3849672A1 (en) 2021-07-21
WO2020055278A1 (en) 2020-03-19

Similar Documents

Publication Publication Date Title
US20100172865A1 (en) Methods of enhancing hair growth
JP2004538308A (en) Skin treatment using phosphoric acid derivatives of electron transfer agents
US20200206094A1 (en) Compositions Containing Plant Mucilage
CN103079536B (en) Prevention depilation and trichogenous compositions
EA024483B1 (en) Topical composition for treatment of hyperkeratotic skin
CA2897518C (en) Topical dermatological composition including a cationic antimicrobial peptide coupled with a lipid and hyaluronic acid
EP3091961A1 (en) Exfoliative hair retention-promoting formulation
WO2013050959A1 (en) Composition for the treatment of skin lesions
KR102354954B1 (en) Fish Oil Topical Composition
JP2021521281A (en) Topical composition consisting of cod liver oil for the treatment of wounds and skin disorders
US20250360076A1 (en) Compositions containing plant mucilage
US20200030398A1 (en) Skin care composition
RS58997B1 (en) Composition against aging of the intimate area skin
JP6656553B1 (en) Beauty method
EP2086554A2 (en) Methods and compositions for treatment of skin conditions
US20110217260A1 (en) Method of enhancing eyelash and eye brow hair growth
EP3895686B1 (en) Natural composition for hair growth stimulation and hair loss prevention and treatment
EP3895685A1 (en) Natural composition for hair growth stimulation and hair loss prevention and treatment without preservatives
RU2722823C2 (en) Cosmetic composition for treating and preventing acne on skin
CN114081845B (en) Composition, application thereof and cosmetics
Igielska-Kalwat Regeneration of the skin of oncology patients after radiation therapy using upcycled fish collagen
RU2815778C1 (en) Hair growth agent and method of using it
KR101040011B1 (en) Demodex fungicide
CN118717557A (en) A skin repair composition and its preparation method and application
CN104666405A (en) Application of traditional Chinese medicine composition in preparing medicament for treating acne